Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 10(1): e0115864, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25565273

RESUMEN

Housaku Monogatari (HM) is a plant activator prepared from a yeast cell wall extract. We examined the efficacy of HM application and observed that HM treatment increased the resistance of Arabidopsis thaliana and Brassica rapa leaves to bacterial and fungal infections. HM reduced the severity of bacterial leaf spot and anthracnose on A. thaliana and Brassica crop leaves with protective effects. In addition, gene expression analysis of A. thaliana plants after treatment with HM indicated increased expression of several plant defense-related genes. HM treatment appears to induce early activation of jasmonate/ethylene and late activation of salicylic acid (SA) pathways. Analysis using signaling mutants revealed that HM required SA accumulation and SA signaling to facilitate resistance to the bacterial pathogen Pseudomonas syringae pv. maculicola and the fungal pathogen Colletotrichum higginsianum. In addition, HM-induced resistance conferred chitin-independent disease resistance to bacterial pathogens in A. thaliana. These results suggest that HM contains multiple microbe-associated molecular patterns that activate defense responses in plants. These findings suggest that the application of HM is a useful tool that may facilitate new disease control methods.


Asunto(s)
Arabidopsis/genética , Brassica/genética , Colletotrichum/efectos de los fármacos , Reguladores del Crecimiento de las Plantas/farmacología , Pseudomonas syringae/efectos de los fármacos , Arabidopsis/metabolismo , Arabidopsis/microbiología , Proteínas de Arabidopsis/genética , Proteínas de Arabidopsis/metabolismo , Brassica/metabolismo , Brassica/microbiología , Pared Celular/química , Pared Celular/metabolismo , Quitinasas/genética , Quitinasas/metabolismo , Colletotrichum/fisiología , Ciclopentanos/metabolismo , Resistencia a la Enfermedad/genética , Etilenos/metabolismo , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Oxilipinas/metabolismo , Enfermedades de las Plantas/microbiología , Reguladores del Crecimiento de las Plantas/química , Reguladores del Crecimiento de las Plantas/metabolismo , Hojas de la Planta/metabolismo , Hojas de la Planta/microbiología , Pseudomonas syringae/fisiología , Ácido Salicílico/metabolismo , Transducción de Señal/efectos de los fármacos , Levaduras/química , Levaduras/metabolismo
2.
Nihon Shokakibyo Gakkai Zasshi ; 110(12): 2119-26, 2013 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-24305101

RESUMEN

A 46-year-old man with cancer of the sigmoid colon with hepatic metastasis underwent sigmoidectomy, partial hepatectomy, and cholecystectomy in May 2008. He subsequently received 10 cycles of a modified 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) regimen as adjuvant chemotherapy from June 2008 to December 2008, following which he developed thrombocytopenia and splenomegaly. In May 2011, upper gastrointestinal endoscopy was performed, which revealed esophageal and gastric varices. The varices were treated endoscopically with ligation and balloon-occluded retrograde transvenous obliteration. A liver biopsy was performed to determine the cause of the portal hypertension in the absence of severe hepatic dysfunction or liver cirrhosis. The biopsy revealed obliteration of the peripheral portal veins with sinusoidal dilatation without fibrosis or inflammatory cell infiltration in the hepatic lobules. Oxaliplatin-based chemotherapy has been associated with hepatovascular injury, such as sinusoidal dilatation and fibrosis, resulting in non-cirrhotic portal hypertension as seen in this case.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Hipertensión Portal/inducido químicamente , Antimetabolitos Antineoplásicos/administración & dosificación , Antineoplásicos/administración & dosificación , Quimioterapia Adyuvante/efectos adversos , Fluorouracilo/administración & dosificación , Humanos , Leucovorina/administración & dosificación , Masculino , Persona de Mediana Edad , Compuestos Organoplatinos/administración & dosificación , Oxaliplatino , Neoplasias del Colon Sigmoide/tratamiento farmacológico
3.
J Nutr Sci Vitaminol (Tokyo) ; 48(4): 298-304, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12489821

RESUMEN

The effects of brewer's yeast, casein, and soy protein intakes on the absorption and retention as well as the incorporation into hemoglobin and systemic iron stores of dietary iron were examined in an animal experiment with growing rats. Relative biological values (RBV) of iron in the rats fed casein (C), soy protein (SP), and yeast (Y) diets were 1.00, 0.31, and 1.77, respectively. The apparent absorption of iron in Y-diet-fed rats was significantly higher than that in C- or SP-diet-fed rats. The hemoglobin regeneration efficiency (HRE) of iron in Y group was significantly higher than those in C and SP groups. As a result of search for iron-absorptive enhancers (IAE) in yeast, RBV and HRE of the yeast-cell-wall-including diet turned out to be significantly higher than those of its lacking diet. These results suggest that IAE occurring in the yeast cell wall may be effective for iron absorption.


Asunto(s)
Caseínas/farmacología , Hierro de la Dieta/farmacocinética , Saccharomyces cerevisiae/fisiología , Proteínas de Soja/farmacología , Animales , Disponibilidad Biológica , Pared Celular/metabolismo , Hemoglobinas/metabolismo , Absorción Intestinal , Masculino , Valor Nutritivo , Ratas , Ratas Wistar
4.
Biosci Biotechnol Biochem ; 66(8): 1744-7, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12353639

RESUMEN

The effects of brewer's yeast cell walls and two of its components, glucan and mannan, on the absorption of 59Fe by anemic rats were investigated. After administration of the label, the percentage of 59Fe taken up into the blood of group given glucan was generally similar to that of a group given yeast cell walls, both values were higher than in controls. The incorporation of 59Fe into the small intestines was higher in the group given glucan than in the controls or a group given a glucan-mannan mixture. Glucan is the main substance in yeast cell walls that increases iron absorption.


Asunto(s)
Anemia Ferropénica/metabolismo , Glucanos/farmacología , Hierro/farmacocinética , Saccharomyces cerevisiae/metabolismo , Anemia Ferropénica/tratamiento farmacológico , Animales , Área Bajo la Curva , Pared Celular/metabolismo , Absorción Intestinal/efectos de los fármacos , Intestino Delgado/metabolismo , Hierro/sangre , Hierro/farmacología , Masculino , Mananos/farmacología , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...